The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.
The pre-therapeutic classification of co-morbidity in chronic disease
Abstract
In a patient with a particular index disease, the term co-morbidity refers to any additional co-existing ailment. The failure to classify and analyze co-morbid diseases has led to many difficulties in medical statistics. The omissions create misleading data in mortality rates for a general population, and in fatality rates for an individual disease. In particular, neglect of co-morbidity may cause spurious comparisons during the planning and evaluation of treatment for patients with apparently identical diagnoses. Co-morbidity can alter the clinical course of patients with the same diagnosis by affecting the time of detection, prognostic anticipations, therapeutic selection, and post-therapeutic outcome of the index disease. In addition to these direct effects on clinical course, co-morbidity plays a role in intellectual decisions that may alter the statistical categories of diagnostic classification. These decisions deal with the attribution of symptoms in 'polypathic' patients and with the selection of an inception manifestation for the index disease. In order to maintain consistency in the management of research data, certain principles of co-morbid differential diagnosis can be developed according to anatomic relation, pathogenetic interplay, and chronometric features of the diseases under consideration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to the oppositional model of tolerance, continued drug treatment may recruit processes that oppose the initial acute effects of a drug.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [47]
In the citing paper
“However, factors such as duration and type of treatment, prior history of exposure to antidepressants, and augmenting and switch strategies may carry much more weight than genetic predisposition [42,47,48].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [47]
In the citing paper
“For addressing such complexities and the unsatisfactory degree of remission that current therapeutic strategies entail [19], the sequential model of treatment has been developed [49, 50].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [49]
Citations
Cites
Ledley, R. S., & Lusted, L. B. (1959) · Science · doi:10.1126/science.130.3366.9 · Cited by 991
Introduction to Medical Decision Making.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-5-1051_1 · Cited by 478
A Mathematical Approach to Medical Diagnosis: Application to Congenital Heart Disease
Warner, H. R. (1961) · JAMA · doi:10.1001/jama.1961.03040290005002 · Cited by 369
Feinstein, A. R., Pritchett, J. A., & Schimpff, C. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.123.3.323 · Cited by 70
Self-citationThe Epidemiology of Cancer Therapy: III. The Management of Imperfect Data
Feinstein, A. R., Pritchett, J. A., & Schimpff, C. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300140094023 · Cited by 66
Self-citationFeinstein, A. R. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1037 · Cited by 62
Self-citationSome problems in the use of multiple causes of death
Guralnick, L. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90031-2 · Cited by 52
Clinical Epidemiology: III. The Clinical Design of Statistics in Therapy
Feinstein, A. R. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1287 · Cited by 38
Self-citationComputing Survival Rates for Chronic Disease Patients
Axtell, L. M. (1963) · JAMA · doi:10.1001/jama.1963.03710130021004 · Cited by 36
Computer-aided diagnosis of cardiovascular disorders
Bruce, R. A., & Yarnall, S. R. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90121-4 · Cited by 33
Research works printed but not linked: 1
- Andrews, 1968, Importance of clinical and co-morbid features in the staging of cancer, Clin Res, 16, 356
Cited by
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Aging with multimorbidity: A systematic review of the literature
Marengoni, A., Angleman, S., Melis, R., Mangialasche, F., Karp, A., Garmen, A., Meinow, B., & Fratiglioni, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.003 · Cited by 3,092
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
“In this respect, Van den Akker et al. [54] made a useful distinction between, on the one hand, multimorbidity (i.e., the cooccurrence of multiple chronic or acute diseases and medical conditions in one person) and, on the other hand, comorbidity as defined by Feinstein [1].”
Influential
Metadata
- Authors
- Feinstein, A. R.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Feinstein, Alvan R.
- Venue
- Journal of Chronic Diseases
- Publisher
- Elsevier BV
- Published
- 1970-12
- Volume
- 23
- Issue
- 7
- Pages
- 455-468
- ISSN
- 0021-9681 (ISSN-L)
- OpenAlex
- W1979767919
- Cited by
- 1,544
- References
- 12
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 80 · 2023: 65 · 2022: 105 · 2021: 76 · 2020: 83 · 2019: 76 · 2018: 81 · 2017: 72 · 2016: 80 · 2015: 56 · 2014: 80 · 2013: 59 · 2012: 61
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Chronic Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- comorbidities, chronic disease, differential diagnosis, mortality rates, fatality rate, prognostic factors, diagnostic classification
- MeSH terms
- Chronic Disease, Diagnosis, Differential, Humans, Neoplasms, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pre-therapeutic classification of co-morbidity in chronic disease. https://app.cochat.ai/papers/10.1016/0021-9681(70)90054-8
- The paper
- Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases. https://doi.org/10.1016/0021-9681(70)90054-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.